Earnings History Data for Avalo Therapeutics (AVTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Avalo Therapeutics

Avalo Therapeutics Inc. is a clinical-stage precision medicine company which discovers, develops and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology and rare genetic diseases. Avalo Therapeutics Inc., formerly known as Cerecor, is based in WAYNE, Pa.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
04-08-2022 PM AVTX Avalo Therapeutics 33.00 -1.38 -1.80 0.00 Avalo Therapeutics GAAP EPS of -$1.38 beats by $0.37, revenue of $1.03M beats by $0.29M
[8/4/2022 9:01 AM]
4.01 0.36 
(9.86%)
3.92 -0.40 
(-9.26%)
2.42 - 38.88 141,876 40,000 51,552
05-05-2022 PM AVTX Avalo Therapeutics 48.00 -0.20 -0.14 0.00 Avalo Therapeutics GAAP EPS of -$0.20 misses by $0.08, revenue of $1.17M beats by $0.65M
[5/5/2022 8:55 AM]
0.3277 -0.07 
(-16.81%)
0.40 0.01 
(1.55%)
0.31 - 3.70 1,091,035 470,000 905
09-11-2021 AH AVTX Avalo Therapeutics, Inc. 266.19 -0.17 -0.19 -0.16 Avalo Therapeutics EPS beats by $0.01, beats on revenue
[11/9/2021 4:54 PM]
2.28 -0.04 
(-1.72%)
2.21 -0.11 
(-4.74%)
1.99 - 4.50 243,289 330,000 507